Previous Article | Next Article 
Infection and Immunity, July 2006, p. 4133-4141, Vol. 74, No. 7
0019-9567/06/$08.00+0 doi:10.1128/IAI.02094-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Sialic Acid-Binding Immunoglobulin-Like Lectin 7 Mediates Selective Recognition of Sialylated Glycans Expressed on Campylobacter jejuni Lipooligosaccharides
Tony Avril,1,
Eric R. Wagner,2
Hugh J. Willison,2 and
Paul R. Crocker1*
Wellcome Trust Biocentre, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom,1
Division of Clinical Neurosciences, University of Glasgow, Southern General Hospital, Glasgow G51 4TF, United Kingdom2
Received 29 December 2005/
Returned for modification 21 March 2006/
Accepted 24 April 2006
siglecs are a family of sialic-acid binding immunoglobulin-like lectins mostly expressed by cells of the immune system that have the potential to interact with sialylated glycans expressed not only on host cells but also on certain pathogens. Campylobacter jejuni is a common pathogen of humans that expresses surface lipooligosaccharides (LOS) that can be modified with ganglioside-like terminal structures in the core oligosaccharides. In this study, we examined the interaction of 10 siglecs with LOS purified from four different C. jejuni isolates expressing GM1-like, GD1a-like, GD3-like, and GT1a-like oligosaccharides. Of all siglecs examined, only Siglec-7 exhibited specific, sialic acid-dependent interactions with C. jejuni LOS in solid-phase binding assays. Binding was especially prominent with LOS from the HS:19(GM1+ GT1a+) isolate, with weaker binding with LOS from the HS:19(GD3+) isolate. Binding of Siglec-7 was also observed with intact bacteria expressing these LOS structures. Specific binding of HS:19(GM1+ GT1a+) bacteria was demonstrated with Siglec-7 expressed on transfected Chinese hamster ovary cells and with peripheral blood leukocytes, among which HS:19(GM1+ GT1a+) bacteria bound selectively to both natural killer cells and monocytes which naturally express Siglec-7. These results raise the possibility that, in addition to their role in generating autoimmune antibody responses, C. jejuni LOS could interact with Siglec-7 expressed by leukocytes, modulate the host-pathogen interaction, and contribute to the clinical outcome and the development of secondary complications such as Guillain-Barré syndrome.
* Corresponding author. Mailing address: Wellcome Trust Biocentre, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom. Phone: 44 1382 345781. Fax: 44 1382 345783. E-mail:
p.r.crocker{at}dundee.ac.uk.
Editor: V. J. DiRita
Present address: UPRES EA 3889 Immunologie Hématologie, Department of Biology, Centre Eugène Marquis, 35042 Rennes, France.
Infection and Immunity, July 2006, p. 4133-4141, Vol. 74, No. 7
0019-9567/06/$08.00+0 doi:10.1128/IAI.02094-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Brunetta, E., Fogli, M., Varchetta, S., Bozzo, L., Hudspeth, K. L., Marcenaro, E., Moretta, A., Mavilio, D.
(2009). The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. Blood
114: 3822-3830
[Abstract]
[Full Text]
-
Almagro-Moreno, S., Boyd, E. F.
(2009). Sialic Acid Catabolism Confers a Competitive Advantage to Pathogenic Vibrio cholerae in the Mouse Intestine. Infect. Immun.
77: 3807-3816
[Abstract]
[Full Text]
-
Carlin, A. F., Chang, Y.-C., Areschoug, T., Lindahl, G., Hurtado-Ziola, N., King, C. C., Varki, A., Nizet, V.
(2009). Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. JEM
206: 1691-1699
[Abstract]
[Full Text]
-
Schoenhofen, I. C, Vinogradov, E., Whitfield, D. M, Brisson, J.-R., Logan, S. M
(2009). The CMP-legionaminic acid pathway in Campylobacter: Biosynthesis involving novel GDP-linked precursors. Glycobiology
19: 715-725
[Abstract]
[Full Text]
-
Rinaldi, S., Brennan, K. M, Goodyear, C. S, O'Leary, C., Schiavo, G., Crocker, P. R, Willison, H. J
(2009). Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays. Glycobiology
19: 789-796
[Abstract]
[Full Text]
-
Walter, R. B., Raden, B. W., Zeng, R., Hausermann, P., Bernstein, I. D., Cooper, J. A.
(2008). ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2. J. Leukoc. Biol.
83: 200-211
[Abstract]
[Full Text]
-
Severi, E., Hood, D. W., Thomas, G. H.
(2007). Sialic acid utilization by bacterial pathogens. Microbiology
153: 2817-2822
[Abstract]
[Full Text]
-
Tateno, H., Li, H., Schur, M. J., Bovin, N., Crocker, P. R., Wakarchuk, W. W., Paulson, J. C.
(2007). Distinct Endocytic Mechanisms of CD22 (Siglec-2) and Siglec-F Reflect Roles in Cell Signaling and Innate Immunity. Mol. Cell. Biol.
27: 5699-5710
[Abstract]
[Full Text]
-
Carlin, A. F., Lewis, A. L., Varki, A., Nizet, V.
(2007). Group B Streptococcal Capsular Sialic Acids Interact with Siglecs (Immunoglobulin-Like Lectins) on Human Leukocytes. J. Bacteriol.
189: 1231-1237
[Abstract]
[Full Text]
-
Avril, T., North, S. J., Haslam, S. M., Willison, H. J., Crocker, P. R.
(2006). Probing the cis interactions of the inhibitory receptor Siglec-7 with {alpha}2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of {alpha}2,8-sialyltransferase gene expression. J. Leukoc. Biol.
80: 787-796
[Abstract]
[Full Text]